Price MA, Hamm L. Synergies in the operationalization of clinical and observational studies. Presented at the 8th Annual SCOPE Summit Conference; January 24, 2017. Miami, FL.
Davis K, Asiimwe A, Zografos L, McSorley D. Evaluation of risk minimisation activities for cyproterone acetate 2 mg/ethinylestradiol 35 μg. Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):309-10.
Zografos LJ, Andrews E, Whalley D, Petraro P, Vassilev Z. Use of cognitive testing to optimize questionnaire wording and mode of administration in the evaluation of risk minimization activities. Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):319-20.
Heaney CD, Wing S, Campbell RL, Caldwell D, Hopkins B, Richardson D, Yeatts K. Relation between malodor, ambient hydrogen sulfide, and health in a community bordering a landfill. Environ Res. 2011 Aug;111(6):847-52. doi: 10.1016/j.envres.2011.05.021.
Jackson LM. Home study scores and mode of recruitment as indicators of field interviewer longevity and performance on the national household survey on drug abuse. Poster presented at the 20th Annual Southern Association for Public Opinion Research Conference; October 2001.